Hadas Givon

Head of Regulatory Affairs at Pi-Cardia

Hadas Givon has over 13 years of experience in the field of clinical research and regulatory affairs. Hadas currently serves as the Head of Regulatory Affairs at Pi-Cardia since August 2021. Prior to this role, they held the position of Head of clinical and regulatory affairs at Ella Therapeutics from June 2019 to July 2021.

Their previous experience includes working as a Senior Clinical Trial Manager at Exalenz Bioscience Ltd. from July 2017 to July 2019. Hadas also worked as a Senior Clinical Research Associate at QuintilesIMS from January 2015 to August 2017.

Hadas Givon began their career as a Clinical Research Associate at Novatrials in June 2012, and later held the role of Clinical Research Associate at Novo Nordisk A/S from January 2008 to December 2009.

Overall, Hadas Givon has demonstrated expertise and progression in managing clinical trials, regulatory affairs, and clinical research in various organizations throughout their career.

Hadas Givon holds a Master of Business Administration (MBA) degree in Healthcare Innovation, which was obtained from Reichman University in the years 2018 to 2019. Before that, they pursued a Master of Science (MSc) degree in Biology, with a focus on General Biology, at Bar-Ilan University from 2009 to 2011. Prior to their master's degree, they completed their Bachelor of Science (BSc) in Biology/Biological Sciences, General at Bar-Ilan University from 2003 to 2006.

In addition to their formal education, Hadas Givon has acquired several certifications. Hadas obtained a certification in the Regulation of Medical Devices from Physio-Logic Ltd. in January 2022. In January 2021, they received a certification in the Regulation of Digital Health from the same institution. In February 2020, Hadas acquired a certification in Drug Development from Coursera. Earlier in their career, they earned a Clinical Research Associate Certification (CRA) from Bioforum the Data Masters in September 2007. Lastly, they hold a certification in GCP for Clinical Investigations of Drugs and Devices from CITI Program, A Division of BRANY, although the specific date of obtaining this certification is not available.

Links

Previous companies

IQVIA logo
Novo Nordisk logo

Timeline

  • Head of Regulatory Affairs

    June, 2022 - present

  • Clinical Trial Manager

    July, 2021